Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Personalized Cancer Vaccines Market Growth (Status and Outlook) 2022-2028

  • LP 4858610
  • 104 Pages
  • February 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Personalized Cancer Vaccines will have significant change from previous year. According to our (LP Information) latest study, the global Personalized Cancer Vaccines market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Personalized Cancer Vaccines market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Personalized Cancer Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Personalized Cancer Vaccines market, reaching US$ million by the year 2028. As for the Europe Personalized Cancer Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Personalized Cancer Vaccines players cover Advaxis Inc, Personalis, Hoffmann-La Roche Ltd, and BioNtech, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Personalized Cancer Vaccines market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

By Cancer Type

Lung Cancer

Breast Cancer

Colorectal Cancer

Leukemia

Prostate Cancer

Cervical Cancer

Glioblastoma

Others

By Mechanism of Action Type

Tumor-associated antigens (TAAs)

Tumor-specific antigens (TSAs)

Somatic Mutations in Cancer Pharmacogenomics

Pharmacogenomics towards Genomic Polymorphism

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospitals

Homecare

Specialty Clinics

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Advaxis Inc

Personalis

Hoffmann-La Roche Ltd

BioNtech

Celldex

CureVac AG

Genetech

Genocea

Gritstone Oncology

ISA Pharmaceuticals

Merck

Moderna Therapeutics

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Personalized Cancer Vaccines Market Size 2017-2028

2.1.2 Personalized Cancer Vaccines Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Personalized Cancer Vaccines Segment by Type

2.2.1 Lung Cancer

2.2.2 Breast Cancer

2.2.3 Colorectal Cancer

2.2.4 Leukemia

2.2.5 Prostate Cancer

2.2.6 Cervical Cancer

2.2.7 Glioblastoma

2.2.8 Others

2.3 Personalized Cancer Vaccines Market Size by Type

2.3.1 Personalized Cancer Vaccines Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Personalized Cancer Vaccines Market Size Market Share by Type (2017-2022)

2.4 Personalized Cancer Vaccines Segment by Application

2.4.1 Hospitals

2.4.2 Homecare

2.4.3 Specialty Clinics

2.4.4 Others

2.5 Personalized Cancer Vaccines Market Size by Application

2.5.1 Personalized Cancer Vaccines Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Personalized Cancer Vaccines Market Size Market Share by Application (2017-2022)

3 Personalized Cancer Vaccines Market Size by Player

3.1 Personalized Cancer Vaccines Market Size Market Share by Players

3.1.1 Global Personalized Cancer Vaccines Revenue by Players (2020-2022)

3.1.2 Global Personalized Cancer Vaccines Revenue Market Share by Players (2020-2022)

3.2 Global Personalized Cancer Vaccines Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Personalized Cancer Vaccines by Regions

4.1 Personalized Cancer Vaccines Market Size by Regions (2017-2022)

4.2 Americas Personalized Cancer Vaccines Market Size Growth (2017-2022)

4.3 APAC Personalized Cancer Vaccines Market Size Growth (2017-2022)

4.4 Europe Personalized Cancer Vaccines Market Size Growth (2017-2022)

4.5 Middle East & Africa Personalized Cancer Vaccines Market Size Growth (2017-2022)

5 Americas

5.1 Americas Personalized Cancer Vaccines Market Size by Country (2017-2022)

5.2 Americas Personalized Cancer Vaccines Market Size by Type (2017-2022)

5.3 Americas Personalized Cancer Vaccines Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Personalized Cancer Vaccines Market Size by Region (2017-2022)

6.2 APAC Personalized Cancer Vaccines Market Size by Type (2017-2022)

6.3 APAC Personalized Cancer Vaccines Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Personalized Cancer Vaccines by Country (2017-2022)

7.2 Europe Personalized Cancer Vaccines Market Size by Type (2017-2022)

7.3 Europe Personalized Cancer Vaccines Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Personalized Cancer Vaccines by Region (2017-2022)

8.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2017-2022)

8.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Personalized Cancer Vaccines Market Forecast

10.1 Global Personalized Cancer Vaccines Forecast by Regions (2023-2028)

10.1.1 Global Personalized Cancer Vaccines Forecast by Regions (2023-2028)

10.1.2 Americas Personalized Cancer Vaccines Forecast

10.1.3 APAC Personalized Cancer Vaccines Forecast

10.1.4 Europe Personalized Cancer Vaccines Forecast

10.1.5 Middle East & Africa Personalized Cancer Vaccines Forecast

10.2 Americas Personalized Cancer Vaccines Forecast by Country (2023-2028)

10.2.1 United States Personalized Cancer Vaccines Market Forecast

10.2.2 Canada Personalized Cancer Vaccines Market Forecast

10.2.3 Mexico Personalized Cancer Vaccines Market Forecast

10.2.4 Brazil Personalized Cancer Vaccines Market Forecast

10.3 APAC Personalized Cancer Vaccines Forecast by Region (2023-2028)

10.3.1 China Personalized Cancer Vaccines Market Forecast

10.3.2 Japan Personalized Cancer Vaccines Market Forecast

10.3.3 Korea Personalized Cancer Vaccines Market Forecast

10.3.4 Southeast Asia Personalized Cancer Vaccines Market Forecast

10.3.5 India Personalized Cancer Vaccines Market Forecast

10.3.6 Australia Personalized Cancer Vaccines Market Forecast

10.4 Europe Personalized Cancer Vaccines Forecast by Country (2023-2028)

10.4.1 Germany Personalized Cancer Vaccines Market Forecast

10.4.2 France Personalized Cancer Vaccines Market Forecast

10.4.3 UK Personalized Cancer Vaccines Market Forecast

10.4.4 Italy Personalized Cancer Vaccines Market Forecast

10.4.5 Russia Personalized Cancer Vaccines Market Forecast

10.5 Middle East & Africa Personalized Cancer Vaccines Forecast by Region (2023-2028)

10.5.1 Egypt Personalized Cancer Vaccines Market Forecast

10.5.2 South Africa Personalized Cancer Vaccines Market Forecast

10.5.3 Israel Personalized Cancer Vaccines Market Forecast

10.5.4 Turkey Personalized Cancer Vaccines Market Forecast

10.5.5 GCC Countries Personalized Cancer Vaccines Market Forecast

10.6 Global Personalized Cancer Vaccines Forecast by Type (2023-2028)

10.7 Global Personalized Cancer Vaccines Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Advaxis Inc

11.1.1 Advaxis Inc Company Information

11.1.2 Advaxis Inc Personalized Cancer Vaccines Product Offered

11.1.3 Advaxis Inc Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Advaxis Inc Main Business Overview

11.1.5 Advaxis Inc Latest Developments

11.2 Personalis

11.2.1 Personalis Company Information

11.2.2 Personalis Personalized Cancer Vaccines Product Offered

11.2.3 Personalis Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Personalis Main Business Overview

11.2.5 Personalis Latest Developments

11.3 Hoffmann-La Roche Ltd

11.3.1 Hoffmann-La Roche Ltd Company Information

11.3.2 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Product Offered

11.3.3 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Hoffmann-La Roche Ltd Main Business Overview

11.3.5 Hoffmann-La Roche Ltd Latest Developments

11.4 BioNtech

11.4.1 BioNtech Company Information

11.4.2 BioNtech Personalized Cancer Vaccines Product Offered

11.4.3 BioNtech Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 BioNtech Main Business Overview

11.4.5 BioNtech Latest Developments

11.5 Celldex

11.5.1 Celldex Company Information

11.5.2 Celldex Personalized Cancer Vaccines Product Offered

11.5.3 Celldex Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Celldex Main Business Overview

11.5.5 Celldex Latest Developments

11.6 CureVac AG

11.6.1 CureVac AG Company Information

11.6.2 CureVac AG Personalized Cancer Vaccines Product Offered

11.6.3 CureVac AG Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 CureVac AG Main Business Overview

11.6.5 CureVac AG Latest Developments

11.7 Genetech

11.7.1 Genetech Company Information

11.7.2 Genetech Personalized Cancer Vaccines Product Offered

11.7.3 Genetech Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Genetech Main Business Overview

11.7.5 Genetech Latest Developments

11.8 Genocea

11.8.1 Genocea Company Information

11.8.2 Genocea Personalized Cancer Vaccines Product Offered

11.8.3 Genocea Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Genocea Main Business Overview

11.8.5 Genocea Latest Developments

11.9 Gritstone Oncology

11.9.1 Gritstone Oncology Company Information

11.9.2 Gritstone Oncology Personalized Cancer Vaccines Product Offered

11.9.3 Gritstone Oncology Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Gritstone Oncology Main Business Overview

11.9.5 Gritstone Oncology Latest Developments

11.10 ISA Pharmaceuticals

11.10.1 ISA Pharmaceuticals Company Information

11.10.2 ISA Pharmaceuticals Personalized Cancer Vaccines Product Offered

11.10.3 ISA Pharmaceuticals Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 ISA Pharmaceuticals Main Business Overview

11.10.5 ISA Pharmaceuticals Latest Developments

11.11 Merck

11.11.1 Merck Company Information

11.11.2 Merck Personalized Cancer Vaccines Product Offered

11.11.3 Merck Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Merck Main Business Overview

11.11.5 Merck Latest Developments

11.12 Moderna Therapeutics

11.12.1 Moderna Therapeutics Company Information

11.12.2 Moderna Therapeutics Personalized Cancer Vaccines Product Offered

11.12.3 Moderna Therapeutics Personalized Cancer Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Moderna Therapeutics Main Business Overview

11.12.5 Moderna Therapeutics Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Personalized Cancer Vaccines Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Lung Cancer

Table 3. Major Players of Breast Cancer

Table 4. Major Players of Colorectal Cancer

Table 5. Major Players of Leukemia

Table 6. Major Players of Prostate Cancer

Table 7. Major Players of Cervical Cancer

Table 8. Major Players of Glioblastoma

Table 9. Major Players of Others

Table 10. Personalized Cancer Vaccines Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Personalized Cancer Vaccines Market Size by Type (2017-2022) & ($ Millions)

Table 12. Global Personalized Cancer Vaccines Market Size Market Share by Type (2017-2022)

Table 13. Personalized Cancer Vaccines Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 14. Global Personalized Cancer Vaccines Market Size by Application (2017-2022) & ($ Millions)

Table 15. Global Personalized Cancer Vaccines Market Size Market Share by Application (2017-2022)

Table 16. Global Personalized Cancer Vaccines Revenue by Players (2020-2022) & ($ Millions)

Table 17. Global Personalized Cancer Vaccines Revenue Market Share by Player (2020-2022)

Table 18. Personalized Cancer Vaccines Key Players Head office and Products Offered

Table 19. Personalized Cancer Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 20. New Products and Potential Entrants

Table 21. Mergers & Acquisitions, Expansion

Table 22. Global Personalized Cancer Vaccines Market Size by Regions 2017-2022 & ($ Millions)

Table 23. Global Personalized Cancer Vaccines Market Size Market Share by Regions (2017-2022)

Table 24. Americas Personalized Cancer Vaccines Market Size by Country (2017-2022) & ($ Millions)

Table 25. Americas Personalized Cancer Vaccines Market Size Market Share by Country (2017-2022)

Table 26. Americas Personalized Cancer Vaccines Market Size by Type (2017-2022) & ($ Millions)

Table 27. Americas Personalized Cancer Vaccines Market Size Market Share by Type (2017-2022)

Table 28. Americas Personalized Cancer Vaccines Market Size by Application (2017-2022) & ($ Millions)

Table 29. Americas Personalized Cancer Vaccines Market Size Market Share by Application (2017-2022)

Table 30. APAC Personalized Cancer Vaccines Market Size by Region (2017-2022) & ($ Millions)

Table 31. APAC Personalized Cancer Vaccines Market Size Market Share by Region (2017-2022)

Table 32. APAC Personalized Cancer Vaccines Market Size by Type (2017-2022) & ($ Millions)

Table 33. APAC Personalized Cancer Vaccines Market Size Market Share by Type (2017-2022)

Table 34. APAC Personalized Cancer Vaccines Market Size by Application (2017-2022) & ($ Millions)

Table 35. APAC Personalized Cancer Vaccines Market Size Market Share by Application (2017-2022)

Table 36. Europe Personalized Cancer Vaccines Market Size by Country (2017-2022) & ($ Millions)

Table 37. Europe Personalized Cancer Vaccines Market Size Market Share by Country (2017-2022)

Table 38. Europe Personalized Cancer Vaccines Market Size by Type (2017-2022) & ($ Millions)

Table 39. Europe Personalized Cancer Vaccines Market Size Market Share by Type (2017-2022)

Table 40. Europe Personalized Cancer Vaccines Market Size by Application (2017-2022) & ($ Millions)

Table 41. Europe Personalized Cancer Vaccines Market Size Market Share by Application (2017-2022)

Table 42. Middle East & Africa Personalized Cancer Vaccines Market Size by Region (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Personalized Cancer Vaccines Market Size Market Share by Region (2017-2022)

Table 44. Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2017-2022) & ($ Millions)

Table 45. Middle East & Africa Personalized Cancer Vaccines Market Size Market Share by Type (2017-2022)

Table 46. Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2017-2022) & ($ Millions)

Table 47. Middle East & Africa Personalized Cancer Vaccines Market Size Market Share by Application (2017-2022)

Table 48. Key Market Drivers & Growth Opportunities of Personalized Cancer Vaccines

Table 49. Key Market Challenges & Risks of Personalized Cancer Vaccines

Table 50. Key Industry Trends of Personalized Cancer Vaccines

Table 51. Global Personalized Cancer Vaccines Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 52. Global Personalized Cancer Vaccines Market Size Market Share Forecast by Regions (2023-2028)

Table 53. Global Personalized Cancer Vaccines Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 54. Global Personalized Cancer Vaccines Market Size Market Share Forecast by Type (2023-2028)

Table 55. Global Personalized Cancer Vaccines Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 56. Global Personalized Cancer Vaccines Market Size Market Share Forecast by Application (2023-2028)

Table 57. Advaxis Inc Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors

Table 58. Advaxis Inc Personalized Cancer Vaccines Product Offered

Table 59. Advaxis Inc Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Advaxis Inc Main Business

Table 61. Advaxis Inc Latest Developments

Table 62. Personalis Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors

Table 63. Personalis Personalized Cancer Vaccines Product Offered

Table 64. Personalis Main Business

Table 65. Personalis Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Personalis Latest Developments

Table 67. Hoffmann-La Roche Ltd Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors

Table 68. Hoffmann-La Roche Ltd Personalized Cancer Vaccines Product Offered

Table 69. Hoffmann-La Roche Ltd Main Business

Table 70. Hoffmann-La Roche Ltd Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Hoffmann-La Roche Ltd Latest Developments

Table 72. BioNtech Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors

Table 73. BioNtech Personalized Cancer Vaccines Product Offered

Table 74. BioNtech Main Business

Table 75. BioNtech Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. BioNtech Latest Developments

Table 77. Celldex Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors

Table 78. Celldex Personalized Cancer Vaccines Product Offered

Table 79. Celldex Main Business

Table 80. Celldex Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Celldex Latest Developments

Table 82. CureVac AG Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors

Table 83. CureVac AG Personalized Cancer Vaccines Product Offered

Table 84. CureVac AG Main Business

Table 85. CureVac AG Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. CureVac AG Latest Developments

Table 87. Genetech Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors

Table 88. Genetech Personalized Cancer Vaccines Product Offered

Table 89. Genetech Main Business

Table 90. Genetech Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Genetech Latest Developments

Table 92. Genocea Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors

Table 93. Genocea Personalized Cancer Vaccines Product Offered

Table 94. Genocea Main Business

Table 95. Genocea Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. Genocea Latest Developments

Table 97. Gritstone Oncology Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors

Table 98. Gritstone Oncology Personalized Cancer Vaccines Product Offered

Table 99. Gritstone Oncology Main Business

Table 100. Gritstone Oncology Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Gritstone Oncology Latest Developments

Table 102. ISA Pharmaceuticals Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors

Table 103. ISA Pharmaceuticals Personalized Cancer Vaccines Product Offered

Table 104. ISA Pharmaceuticals Main Business

Table 105. ISA Pharmaceuticals Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. ISA Pharmaceuticals Latest Developments

Table 107. Merck Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors

Table 108. Merck Personalized Cancer Vaccines Product Offered

Table 109. Merck Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. Merck Main Business

Table 111. Merck Latest Developments

Table 112. Moderna Therapeutics Details, Company Type, Personalized Cancer Vaccines Area Served and Its Competitors

Table 113. Moderna Therapeutics Personalized Cancer Vaccines Product Offered

Table 114. Moderna Therapeutics Main Business

Table 115. Moderna Therapeutics Personalized Cancer Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 116. Moderna Therapeutics Latest Developments

List of Figures

Figure 1. Personalized Cancer Vaccines Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Personalized Cancer Vaccines Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Personalized Cancer Vaccines Market Size Market Share by Type in 2021

Figure 7. Personalized Cancer Vaccines in Hospitals

Figure 8. Global Personalized Cancer Vaccines Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Personalized Cancer Vaccines in Homecare

Figure 10. Global Personalized Cancer Vaccines Market: Homecare (2017-2022) & ($ Millions)

Figure 11. Personalized Cancer Vaccines in Specialty Clinics

Figure 12. Global Personalized Cancer Vaccines Market: Specialty Clinics (2017-2022) & ($ Millions)

Figure 13. Personalized Cancer Vaccines in Others

Figure 14. Global Personalized Cancer Vaccines Market: Others (2017-2022) & ($ Millions)

Figure 15. Global Personalized Cancer Vaccines Market Size Market Share by Application in 2021

Figure 16. Global Personalized Cancer Vaccines Revenue Market Share by Player in 2021

Figure 17. Global Personalized Cancer Vaccines Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Personalized Cancer Vaccines Market Size 2017-2022 ($ Millions)

Figure 19. APAC Personalized Cancer Vaccines Market Size 2017-2022 ($ Millions)

Figure 20. Europe Personalized Cancer Vaccines Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Personalized Cancer Vaccines Market Size 2017-2022 ($ Millions)

Figure 22. Americas Personalized Cancer Vaccines Value Market Share by Country in 2021

Figure 23. Americas Personalized Cancer Vaccines Consumption Market Share by Type in 2021

Figure 24. Americas Personalized Cancer Vaccines Market Size Market Share by Application in 2021

Figure 25. United States Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Personalized Cancer Vaccines Market Size Market Share by Region in 2021

Figure 30. APAC Personalized Cancer Vaccines Market Size Market Share by Application in 2021

Figure 31. China Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Personalized Cancer Vaccines Market Size Market Share by Country in 2021

Figure 38. Europe Personalized Cancer Vaccines Market Size Market Share by Type in 2021

Figure 39. Europe Personalized Cancer Vaccines Market Size Market Share by Application in 2021

Figure 40. Germany Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Personalized Cancer Vaccines Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Personalized Cancer Vaccines Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Personalized Cancer Vaccines Market Size Market Share by Application in 2021

Figure 48. Egypt Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Personalized Cancer Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 54. APAC Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 55. Europe Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 57. United States Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 58. Canada Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 61. China Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 62. Japan Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 63. Korea Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 65. India Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 66. Australia Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 67. Germany Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 68. France Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 69. UK Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 70. Italy Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 71. Russia Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 72. Spain Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 75. Israel Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Personalized Cancer Vaccines Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450